The DOI matches its Crossref record.
The Association Between High Nicotine Dependence and Severe Mental Illness May Be Consistent Across Countries
Abstract
BACKGROUND: Studies all over the world suggest that severe mental illness, including schizophrenia and mood disorders, is associated with tobacco smoking. This study, combining samples from the United States and Spain, had 3 objectives: (1) to test the hypothesis that severely mentally ill patients who smoke are more likely to have a high nicotine dependence when compared with control smokers, (2) to compare frequencies of high nicotine dependence in controls in both countries, and (3) to compare frequencies of high nicotine dependence in severely mentally ill patients in both countries. METHOD: Scores on the Fagerström Test for Nicotine Dependence (FTND) for 4 samples of current daily smokers were analyzed. The sample sizes of the U.S. and Spanish control groups were 129 and 646 subjects, respectively. The diagnoses for the U.S. patients were DSM-IV schizophrenia, 74% (89/120), and DSM-IV mood disorders, 26% (31/120). The diagnoses for the Spanish patients were DSM-IV schizophrenia, 87% (173/199), and DSM-III-R mood disorders, 13% (26/199). High nicotine dependence (FTND score > or = 6) was the dependent variable in 5 logistic regression analyses. RESULTS: The main findings were that (1) severely mentally ill patients had significantly higher frequencies of high nicotine dependence than controls (odds ratio [OR] = 10.59, 95% CI = 7.31 to 15.34) even after controlling for gender, country, interaction between country and mental illness, and age; (2) U.S. controls had significantly higher frequencies of high nicotine dependence than Spanish controls (OR = 3.18, 95% CI = 2.02 to 5.00); and (3) U.S. and Spanish patients did not have significantly different frequencies of high nicotine dependence. CONCLUSION: New studies, specially designed to test for transcultural differences in nicotine dependence, are needed to verify that nicotine dependence in severely mentally ill patients is consistently high and similar in different countries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“our results therefore reflect existing epidemiological evidence demonstrating that schizophrenia patients not only smoke more, but also smoke more heavily (de Leon et al., 2002; de Leon and Diaz, 2005; McClave et al., 2010).”
From DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia (2021) · cites this paper as de Leon et al., 2002
Citations
Cited by
Sorted by citations
Items 101–144 of 144
Genetics of Psychiatric Disorders
Nürnberger, J. I., Berrettini, W. H., & Niculescu, A. B. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_29 · Cited by 9
Williams, M. A., Reddy, G., Quinn, M. J., & Bell, A. M. (2021) · Drug and Chemical Toxicology · doi:10.1080/01480545.2021.1905657 · Cited by 11
Substance Use and Dual Diagnosis Disorders: Future Epidemiology, Determinants, and Policies
Saddichha, S., Schütz, C. G., Sinha, B. N. P., & Manjunatha, N. (2015) · BioMed Research International · doi:10.1155/2015/145905 · Cited by 8
“The AUDIT has been extensively used in both national and Ontario surveys which demonstrate the validity of the instrument in Canadian populations and the utility of the 8+ cutoff [34–36].”
Ansiedad y consumo de tabaco en niños y adolescentes
Becoña, E., & Míguez, M. C. (2004) · Adicciones · doi:10.20882/adicciones.407 · Cited by 8
Self-citationAlrisi, K. A., Al-Maqbali, M., Asiri, W. A., & Sinawi, H. A. (2018) · Oman Medical Journal · doi:10.5001/omj.2018.41 · Cited by 8
Asamsama, O. H., Miller, S. C., Silvestri, M. M., et al. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.09.004 · Cited by 8
Prevalência de tabagismo em uma unidade de internação psiquiátrica de Porto Alegre
Boni, R. B. D., & Pechansky, F. (2003) · Revista de Psiquiatria do Rio Grande do Sul · doi:10.1590/s0101-81082003000300009 · Cited by 7
Zhang, X. Y., Rao, W., Yu, Q., Yu, Y., Kou, C., Tan, Y., Chen, D.-C., Zuo, L., Luo, X., & Soares, J. C. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32398 · Cited by 7
“Schizophrenia patients have a higher prevalence of smoking than the general population or other severely mentally ill patients [de 2015 Wiley Periodicals, Inc. Leon et al., 2002; Winterer, 2010; Dickerson et al., 2013; Hou et al., 2011].”
BackgroundHiguchi, Y., Fujiwara, M., Nakaya, N., Fujimori, M., Hayashibara, C., So, R., Shinkawa, I., Sato, K., Yada, Y., Kodama, M., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2351-9 · Cited by 6
Genetics of Psychiatric Disorders
Nürnberger, J. I., Berrettini, W., & Niculescu, A. B. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_29 · Cited by 6
Tawba, W., Qadiri, M. E., Al-Adhami, M., Almehmeed, N., Al-Rawi, N. H., & Awad, M. (2024) · PeerJ · doi:10.7717/peerj.18167 · Cited by 9
Okoli, C. T. C., Torchalla, I., & Khara, M. (2011) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2011.01847.x · Cited by 5
Horta, R. L., Horta, B. L., & Horta, C. L. (2012) · Psicologia em Revista · doi:10.5752/p.1678-9563.2012v18n2p264 · Cited by 5
Effect of monoamine oxidase B A644G variant on nicotine dependence and/or schizophrenia risk
Pehlıvan, S., Aydın, P. Ç., Uysal, M. A., Çiftçi, H. Ş., Sever, Ü., Yavuz, F. K., Aydın, N., & Nursal, A. F. (2019) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/0101-60830000000186 · Cited by 5
Prescription of psychoactive drugs in patients attended by the SUS at Manhuaçu - MG (Brazil)
Gonçalves, D. P., Silva, I. V., Rangel, L. B. A., & Rezende, L. C. (2011) · Pharmacy Practice · doi:10.4321/s1886-36552011000400004 · Cited by 5
“Tricyclic antidepressants* 4 (12,2) 6 (15,0) 18 (17,6) 50 (30,1) 72 (35,5) 71 (25,1)”
InfluentialVerbal Working Memory in Schizophrenia: Relationship to Cigarette Smoking and Psychopathology
Hazura, H., Wa, W. N., Jamaluddin, R., et al. (2012) · The Malaysian journal of psychiatry · Cited by 4
Tobacco, alcohol and cannabis use in Tunisian patients with schizophrenia
Laqueille, X., Ghodhbane, S., Nacef, F., Choubani, Z., Nehdi, M., Douki, S., & Dervaux, A. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.07.011 · Cited by 3
Tabagisme et schizophrénie : impacts sur la maladie et son traitement
Légaré, N. (2008) · Drogues santé et société · doi:10.7202/016946ar · Cited by 3
Phoenix On Fire: A Phenomenological Study Of A Psychiatric Hospital Fire In Iran.
Nouri, M., Ostadtaghizadeh, A., Aliabadi, S. F., Pashaei-Asl, Y., AlJasem, M., & Aghdash, S. A. (2022) · PubMed Central · Cited by 3
Niv, N., Issa, F., Goldberg, R., Khandekar, P., McGraw, K., Reston, J. T., Ford, S. C., Katz, I. R., & Resnick, S. G. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf035 · Cited by 2
Flórez, J. F. G., & Salazar, D. A. R. (2008) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2
Kang, W. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1089148 · Cited by 1
Smiley, S. L., & Shin, H. (2024) · Substance Use & Misuse · doi:10.1080/10826084.2023.2294984 · Cited by 2
“…using the Fagerström Test for Nicotine Dependence (FTND), a standard instrument for assessing the intensity of physical addiction to nicotine (de Leon et al., 2002, 2003; Diaz et al., 2005; Fagerström, 2012; Fagerström et al., 1990, 1996; Gallus & La Vecchia, 2004; John et al., 2004;…”
MethodAbufarsakh, B., Okoli, C. T. C., Williams, L. B., Darville, A. K., Garcia, A. R., & Martin, C. A. (2025) · Journal of the American Psychiatric Nurses Association · doi:10.1177/10783903251356617 · Cited by 1
“…the disproportionately high rates of tobacco use observed in people with MI increase the likelihood of nicotine dependence (ND; Benowitz, 2010; de Leon et al., 2002; Grant et al., 2004), which significantly exacerbates tobacco-related morbidity (Jamal et al., 2012) and makes tobacco use…”
Raddaha, A. H. A., Benowitz, N. L., Stotts, N. A., & Froelicher, E. S. (2015) · Journal of Nursing Education and Practice · doi:10.5430/jnep.v5n5p21 · Cited by 1
“[31–33]”
Ong, K. Y., Ramli, E. R. M., & Ismail, H. C. (2014) · Mental Health and Substance Use · doi:10.1080/17523281.2014.940370 · Cited by 1
ADOLESCENT PREDICTORS OF ADULT SOCIAL AND PSYCHIATRIC ADVERSITIES
Riala, K. (2004) · Cited by 1
Wong, D. V. T. (2009) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Balboa, M. F. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Bhang, S., Choi, S., & Ahn, J. (2013) · Journal of Substance Use · doi:10.3109/14659891.2012.709911
“B, beta coefficient; SE, standard error; DOF, degree of freedom; OR, odds ratio. nicotine dependence using HSI versus FTND (de Leon et al., 2002; Diaz et al., 2005; Kozlowski et al., 1994).”
BackgroundMethodHorta, R. L., Horta, B. L., & Horta, C. L. (2012)
Pontes, A. V. (2009) · Americanae (AECID Library)
Genetik affektiver Störungen – der quantitative Ansatz Syndrom-orientierter Modelle
Stassen, H. H., Angst, J., & Scharfetter, C. (2005) · Vandenhoeck & Ruprecht eBooks · doi:10.13109/9783666451645.219
Nicotine Dependence – Identifying the Contribution of Specific Genes
Hällfors, J. (2017) · Työväentutkimus Vuosikirja
Mackowick, M. K. (2014) · TSpace (University of Toronto)
Smoking topography and smoking-related outcome expectancies in smokers with schizotypy
Stewart, D. W. (2011) · doi:10.31390/gradschool_dissertations.3090
“Interestingly, studies have purported that most individuals with schizophrenia start smoking prior to the onset of schizophrenia (Beratis, Katrivanou, & Gourzis, 2001; de Leon, 1996; de Leon et al., 2002c; 2002a; Kelly & McCreadie, 1999; McEvoy & Brown, 1999; Riala et al., 2004).”
BackgroundThe role of blood-based biomarkers in advancing personalized therapy of schizophrenia
Chen, J., & Schwarz, E. (2017) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2017.1400906
Grempler, J., Steinert, T., & Schmid, P. (2018) · Psychiatrische Praxis · doi:10.1055/a-0574-6695
“[11] de Leon J, Becona E, Gurpegui M et al.”
BackgroundInfluence of Persistence or Cognitive (In)flexibility in Treatment to Quit Smoking
López-Torrecillas, F. (2015) · Addiction & Addictive Disorders · doi:10.24966/aad-7276/100006
“Its factorial structure is consistent [32], and there is a Spanish version of the test [33].”
BackgroundRelation of cigarette smoking and mood disorders to cognitive impairment progression
Grabowski, J., Przybylak, M., Piasecki, T., et al. (2020) · European Journal of Translational and Clinical Medicine · doi:10.31373/ejtcm/127396
“Smoking has been associated with a number of psychiatric disorders for a long time now [13-14].”
BackgroundHoang, M. (2020) · TSpace (University of Toronto)
Current Awareness in Human Psychopharmacology
(2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.458
Editorial, C. (2012) · Psicologia em Revista · doi:10.5752/4540
Metadata
- Authors
- de Leon, J., Becona, E., Gurpegui, M., Gonzalez-Pinto, A., & Diaz, F. J.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-09-15
- Volume
- 63
- Issue
- 9
- Pages
- 812-816
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1974462417
- Cited by
- 144
- References
- 0
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 8 · 2015: 9 · 2014: 9 · 2013: 3 · 2012: 10
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- nicotine dependence, severe mental illness, schizophrenia, mood disorders, smoking, Fagerström Test for Nicotine Dependence, cross-cultural comparison, United States, Spain
- MeSH terms
- Mental Disorders, Cross-Cultural Comparison, Female, Humans, Male, Personality Inventory, Surveys and Questionnaires, Schizophrenia, Schizophrenic Psychology, Severity of Illness Index, Smoking, Spain, Tobacco Use Disorder, United States, Comorbidity, Prevalence, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review